Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer.
Alvotech stock last closed at $9.74, down 1.02% from the previous day, and has decreased 31.79% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.04 percentage points. Alvotech stock is currently +32.52% from its 52-week low of $7.35, and -31.12% from its 52-week high of $14.14.
At the moment, there are 301.81M ALVO shares outstanding. The market capitalization of ALVO is $2.94B. In the last 24 hours, 130,000 ALVO shares were traded.
You need an online brokerage account to access the NASDAQ market and buy ALVO stock.
Based on our research, eToro is the best online stock brokerage. Here's why:
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've selected your brokerage, the next step is to fill out some personal details so you are able to invest in ALVO today.
Now that you've opened your account on the best stock app, your next step is to transfer the money for your investment:
Watch the video below for more details depositing money into your new investment account.
Once you have identified the best place to buy Alvotech stock, it's very important to research their stock prior to investing, so you actually understand the risk as well as the upside.
WallStreetZen was built to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on ALVO's stock page.
Analysts use many financial metrics, analyses, models, and charts to gauge ALVO's true value.
Using relative valuations methods:
You can access additional valuation analysis on ALVO's stock here.
You can dive deeper into what analysts are projecting on the Alvotech stock forecast page.
Last year, ALVO revenue was $587.89M. In the last three year, ALVO's revenue has increased by 238.25% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 9.6%.
You can analyze ALVO's earnings and revenue performance here.
Over the last 12 months, insiders at ALVO have not bought or sold any shares.
Research more about who owns ALVO stock here.
No, Alvotech doesn't provide an income stream by paying out dividends.
One of the biggest reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
You have two main order types:
Press the Open button and eToro will place the order.
If you require more info about investing in stocks on eToro, click the helpful video below:
Now that you own some ALVO shares, you'll want to stay up-to-date on your stock purchase.
Put ALVO on a watchlist to get notified of the latest news about your ALVO stock.
To summarize, here are the 6 steps to buy Alvotech stock:
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Alvotech, click below.